
CDSL Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
CDSL Q1 Results FY27: Uniresearch projects Revenue Rs 294 Cr | PAT Rs 120 Cr (15-analyst consensus). Q4 FY26: Rev Rs 263 Cr | PAT Rs 80 Cr.
Updated: 25 Jun 2026 • 10:50 am
Posted by:

The CDSL outlook is anchored on verified Q4 FY26 actuals and Uniresearch analysis applying the 15-analyst FY27 consensus to Q1 FY26 verified actuals. Uniresearch projects Revenue Rs 294 Cr (+13.6% YoY) and PAT Rs 120 Cr (+17.2% YoY). Prepared by Kunal Singla.
Click Here – Get Free Investment Predictions
CDSL – Uniresearch Prediction
| Metric | Q1 FY26 Actual | Q1 FY27 Uniresearch Prediction | YoY Change | Source |
|---|---|---|---|---|
| CDSL Revenue (Rs Cr) | 259 | 294 | +13.6% | Uniresearch | 15-analyst FY27 consensus |
| PAT (Rs Cr) | 102 | 120 | +17.2% | Uniresearch | 15-analyst FY27 consensus |
| Avg Analyst Target | Rs 1,282 | 12-month view | – | Analyst consensus (15 analysts) |
Predictions apply 15-analyst FY27 consensus (Rev +13.6%, PAT +17.2%) to Q1 FY26 verified actuals.
CDSL Q4 FY26 Key Metrics
| Metric | Q4 FY26 Actual | YoY Change | Source |
|---|---|---|---|
| Revenue (Rs Cr) | 263 | +17.4% YoY | Consolidated quarterly data |
| PAT (Rs Cr) | 80 | -20.0% YoY | Consolidated quarterly data |
Analyst Views on CDSL
The 15-analyst FY27 consensus for CDSL projects revenue growth of +13.6% and profit growth of +17.2%, with an average 12-month target of Rs 1,282.
Key Watchpoints for CDSL
Revenue vs Consensus
The primary watchpoint for CDSL is whether revenue reaches Rs 294 Cr (+13.6% vs Q1 FY26 base Rs 259 Cr).
PAT vs Consensus
Projected PAT Rs 120 Cr (+17.2%) vs Q1 FY26 actual Rs 102 Cr. Q4 FY26 PAT was Rs 80 Cr.
Risks to CDSL
Revenue Shortfall
Revenue below the +13.6% consensus would miss the Rs 294 Cr target.
PAT Pressure
Unexpected cost factors could affect PAT against the +17.2% consensus.
Conclusion: CDSL
The CDSL Uniresearch prediction of Revenue Rs 294 Cr and PAT Rs 120 Cr is derived from the 15-analyst FY27 consensus. Track live updates on Univest.
Track CDSL Live on the Univest Screener
Download the Univest iOS App or Univest Android App for live FY27 alerts.
Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.
FAQs on CDSL
What is Uniresearch’s PAT prediction for CDSL Q1 Results FY27?
Ans. Uniresearch projects CDSL Q1 FY27 PAT at Rs 120 Cr (+17.2% vs Q1 FY26 base Rs 102 Cr).
What is the Revenue prediction for CDSL Q1 Results FY27?
Ans. CDSL Q1 Results Revenue is projected at Rs 294 Cr (+13.6% consensus).
What were CDSL Q1 Results FY27?
Ans. Q4 FY26 Revenue Rs 263 Cr (+17.4% YoY) and PAT Rs 80 Cr (-20.0% YoY).
How many analysts cover CDSL Q1 Results FY27?
Ans. The CDSL Q1 Results prediction uses 15-analyst FY27 consensus, avg target Rs 1,282.
What FY27 consensus applies to CDSL Q1 Results FY27?
Ans. Revenue +13.6% and profit +17.2% (15-analyst FY27 consensus).
What are risks to CDSL Q1 Results FY27?
Ans. Revenue missing +13.6% consensus and PAT pressure vs +17.2% growth target.
What is the Q1 FY26 base for CDSL Q1 Results FY27?
Ans. Q1 FY26 Revenue Rs 259 Cr and PAT Rs 102 Cr.
Recent Articles

Blue Star Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

Avience Biomedicals IPO Listing: Opens at Rs 395 (+90%), Surges to Rs 415, 385x Subscription Delivers Spectacular NSE SME Debut
25 June 2026

NHPC Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

L and T Finance Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Blue Star Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Avience Biomedicals IPO Listing: Opens at Rs 395 (+90%), Surges to Rs 415, 385x Subscription Delivers Spectacular NSE SME Debut
NHPC Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
L and T Finance Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
SBI Life Insurance Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Popular this week
Blue Star Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Avience Biomedicals IPO Listing: Opens at Rs 395 (+90%), Surges to Rs 415, 385x Subscription Delivers Spectacular NSE SME Debut
NHPC Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
L and T Finance Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
SBI Life Insurance Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





